← All stocks

enVVeno Medical Corp

NVNO Scheduled selling only
CIK 0001661053 #5344 in the set updated 17 Sep 2026
Bought (1 mo)
$0.00
out of their own pocket, the only kind of buying there is
Sold (1 mo)
$123.31
$123.31 on a plan · $0.00 straight out of an exercise
Sold at will
$0.00
0 of 1 sales
Net
−$123.31
$0.00 against sales at will

By person

5 insiders · 1 transaction
4.9×

Robert A. Berman holds only 4.9 times base salary in stock. $2.49M of shares against $500.00K in salary for 2024.

Salary from the company's own proxy. The shares are what Robert A. Berman last reported holding, valued at $11.21, the price Common Stock was last bought or sold at on the open market here, on 11 Sep 2026.

Insider
Role
Bought
Sold
Net
Holding
Worth
Change
Duhay Francis
Director
$123.31 (1) scheduled
−$123.31
2,351
$26.35K
BERMAN ROBERT ANDREW
Chief Executive Officer
222,236
$2.49M
+5.7%
Jenusaitis Matthew
Director
16,545
$185.47K
+138.9%
Gray Robert
Director
11,155
$125.05K
+45.7%
Shrivastava Sanjay
Director
9,288
$104.12K
+138.9%

No percentages here. This company's share count has moved by a factor of 30.8 over the window, from 655,521 to 20,216,176 shares. A split, a merger or a large issue changes what the company is, and a holding measured at one point in that run is not a fraction of it at another.

Nothing of that kind in this period.

What was left out

Form 4 filings counted 1
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 1
Sales straight out of an exercise 0
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 0
History held since 26 Sep 2018